Amedisys, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 80.28 million compared to net income of USD 29.58 million a year ago. Basic loss per share from continuing operations was USD 2.46 compared to basic earnings per share from continuing operations of USD 0.91 a year ago. Diluted loss per share from continuing operations was USD 2.46 compared to diluted earnings per share from continuing operations of USD 0.91 a year ago.
For the six months, net loss was USD 55.03 million compared to net income of USD 61.25 million a year ago. Basic loss per share from continuing operations was USD 1.69 compared to basic earnings per share from continuing operations of USD 1.88 a year ago. Diluted loss per share from continuing operations was USD 1.69 compared to diluted earnings per share from continuing operations of USD 1.87 a year ago.